| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195680A1 Incorporation of biologically active molecules into bioactive glasses |
| 02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195639A1 Drug delivery composition for the nasal administration of antiviral agents |
| 02/08/1996 | CA2195630A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | CA2195629A1 Src sh3 binding peptides and methods of isolating and using same |
| 02/08/1996 | CA2195525A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | CA2194999A1 Antiprotozoal cyclic tetrapeptides |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | CA2194177A1 Process for folding of proteins like recombinant hirudin or epidermal growth factor |
| 02/08/1996 | CA2193844A1 Thrombin inhibitors |
| 02/08/1996 | CA2192787A1 Pth or pthrp antagonists |
| 02/07/1996 | EP0695760A1 Novel tumor marker for lung cancer |
| 02/07/1996 | EP0695759A2 Human cancer inhibitory pentapeptide methyl esters |
| 02/07/1996 | EP0695758A2 Human cancer inhibitory pentapeptide amides and esters |
| 02/07/1996 | EP0695757A2 Human cancer inhibitory peptide amides |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695351A1 Isolation, selection and propagation of animal transgenic stem cells |
| 02/07/1996 | EP0695312A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0695309A1 Oxytocin antagonist |
| 02/07/1996 | EP0695308A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 02/07/1996 | EP0695307A1 Modified protein and peptide pharmaceuticals |
| 02/07/1996 | EP0695192A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/07/1996 | EP0695190A1 Regulator regions of g proteins |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/07/1996 | EP0695188A1 Novel bowman-birk inhibitor product for use as an anticarcinogenesis agent |
| 02/07/1996 | EP0695184A1 Hiv protease inhibitors |
| 02/07/1996 | EP0671930A4 Prophylaxis and treatment of adverse oral conditions with biologically active peptides. |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/07/1996 | CN1116427A Polypeptide and anti-hiv agent prepared therefrom |
| 02/07/1996 | CN1116212A Prolonged release preparation and polymers thereof |
| 02/07/1996 | CN1030922C Process for preparation of new amino acid derivatives |
| 02/06/1996 | US5489676 Polypeptides that potentiate bactericidal/permeability-increasing protein and methods for treating bacterial infections |
| 02/06/1996 | US5489670 Laxatives; control intestinal fluid absorption |
| 02/06/1996 | US5489583 2-substituted 3-(4-amidinophenyl)propionic acid derivatives |
| 02/06/1996 | US5489578 Sulfated ligands for l-selectin and methods of treating inflammation |
| 02/06/1996 | US5489577 Stabilized proteinaceous bioactive substance prepared by mixing with an oligosaccharide and kneading with an oil or fat base; ease of administration |
| 02/06/1996 | US5489575 Polypeptides and their use |
| 02/06/1996 | US5489533 Human intercellular adhesion molecule-2; antiinflammatory agents |
| 02/06/1996 | US5489530 Active at ph 3.5-9.0 and not inhibited by sodium deoxycholate; used for producing drugs for therapy of maldigestion |
| 02/06/1996 | US5489525 Monoclonal antibodies to prostate cells |
| 02/06/1996 | US5489524 Chimeric protein that has a human Rho motif and deoxyribonuclease activity |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 02/06/1996 | US5489441 Method for suppressing immune response associated with psoriasis, contact dermatitis and diabetes mellitus |
| 02/06/1996 | US5489430 Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 02/06/1996 | CA2155451A1 Dna sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/02/1996 | CA2154206A1 Human cancer inhibitory pentapeptide amides and esters |
| 02/02/1996 | CA2154205A1 Human cancer inhibitory peptide amides |
| 02/02/1996 | CA2154203A1 Pentapeptide methyl esters |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002654A1 Toxoplasma gondii p30 protein expression cassette |
| 02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002644A1 Mlk receptor tyrosine kinases |
| 02/01/1996 | WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 02/01/1996 | WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 02/01/1996 | WO1996002641A2 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002572A2 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | WO1996002571A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/01/1996 | WO1996002569A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 02/01/1996 | WO1996002567A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | WO1996002560A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002557A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | WO1996002556A2 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002549A1 SUBSTITUTED THIAZOLO[3,2-α]AZEPINE DERIVATIVE |
| 02/01/1996 | WO1996002517A1 Substituted arylsulfonamides, their preparation and use as thrombin-inhibiting medicaments |
| 02/01/1996 | WO1996002500A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | WO1996002288A1 Process for preventing activation of enzyme systems in haemodialysis and in similar procedures with extracorporeal blood circulation |
| 02/01/1996 | WO1996002286A1 Compositions and methods for a bioartificial extracellular matrix |
| 02/01/1996 | WO1996002276A2 Novel polymer gel networks and methods of use |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | WO1996002272A2 Treatment of autoimmune diseases |
| 02/01/1996 | WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | WO1996002270A1 Use of insulin-like growth factor in combination with insulin |
| 02/01/1996 | WO1996002269A1 Therapeutic method and compounds of use therein |
| 02/01/1996 | WO1996002268A1 Inhibition of virus by nitric oxide |
| 02/01/1996 | WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 02/01/1996 | WO1996002265A1 The cellular basis of transplant arteriosclerosis |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | WO1996002256A1 CLEAVAGE OF 5α-REDUCTASE MRNA |
| 02/01/1996 | WO1996002251A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | WO1996002241A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| 02/01/1996 | WO1996002231A1 Inhalation composition |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | WO1996002140A1 ISOLATED p27 PROTEIN AND METHODS FOR ITS PRODUCTION AND USE |
| 02/01/1996 | WO1996002137A1 Wound healing formula |
| 02/01/1996 | WO1995035112A3 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |